Rheonix's Dual Immunoassay, NAAT Zika Test Wins Supplemental SBIR Funding

Apr 19, 2016

NEW YORK (GenomeWeb) – Rheonix announced today it has received an administrative supplement to an existing Small Business Innovation Research Phase I/II grant to develop an automated assay for Zika virus and infection.

The award, which totals $656,414, was granted to Rheonix and collaborators at the New York University College of Dentistry by the National Institute of Dental and Craniofacial Research of the National Institutes of Health.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Hahn Hearing

Stephen Hahn, the nominee to lead the US Food and Drug Administration, underwent a Senate confirmation hearing yesterday, the Washington Post reports.

RNAi Drug for Acute Hepatic Porphyria

The US Food and Drug Administration has approved an RNA interference drug to treat acute hepatic porphyria.

Decade of DTC

Gizmodo looks over the past decade of consumer DNA testing to find the field to be lacking.

Nature Studies Examine Native RNA Sequencing, Nanopore Sequencing Approach to Analyze STR Expansions

In Nature this week: native RNA sequencing and analysis of a human poly(A) transcriptome, nanopore sequencing-based method to analyze short tandem repeat expansions, and more.

Featured White Papers

Orthogonal Methods for Validation and Confirmation of Next-Generation Sequencing Results

Efficient High-Throughput SNP Discovery and Genotyping using Normalized Genotyping-by-Sequencing

SeqSNP Targeted GBS as Alternative for Array Genotyping in Routine Breeding Programs

SeqSNP: A Massively Parallel Marker Screening Approach – High-Speed and High-Throughput Genomic Selection for Plants and Livestock

Dec

02

Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of   FLT3  and  CEBPA

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Dec

04

Featured Webinar

Integrating Genetic Data in Clinical Workflows: How CCPM Established a Personalized Health Framework

This webinar will discuss what it takes to begin realizing precision medicine in a comprehensive clinical infrastructure, with insights from the Colorado Center for Personalized Medicine (CCPM).

Menu

Rheonix's Dual Immunoassay, NAAT Zika Test Wins Supplemental SBIR Funding

To read the full story....

Breaking News

NINDS Awards Coriell Institute $7.7M to Develop Biorepository

Extrachromosomal Oncogene Amplification Involves Rearrangement of Regulatory Elements

Genedrive Receives CE Mark for Hearing Loss Assay

Myriad Genetics BRACAnalysis Approved by Japanese Regulators

DiamiR Wins $492K Grant for Alzheimer's Disease Dx Research

Host Expression Provides Treatment Response Clues in Cutaneous Leishmaniasis

The Scan

Hahn Hearing

RNAi Drug for Acute Hepatic Porphyria

Decade of DTC

Nature Studies Examine Native RNA Sequencing, Nanopore Sequencing Approach to Analyze STR Expansions

Featured White Papers

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of   FLT3  and  CEBPA

Integrating Genetic Data in Clinical Workflows: How CCPM Established a Personalized Health Framework

What's Popular?

Private Equity Firms Cinven, Astorg to Acquire LGC

T2 Biosystems Gets CE Mark for Direct-From-Blood Antimicrobial Resistance Panel

Rheonix Submits MDx System, Triplex Sexually Transmitted Infections Test to FDA

Genedrive Receives CE Mark for Hearing Loss Assay

Paragon Genomics Discusses New Gene Fusion Detection Method, Cystic Fibrosis Panel

Sponsorships